Somatic genomic changes in single Alzheimer’s disease neurons
Miller*, MB, AY Huang*, Kim, Zhou, SL Kirkham, EA Maury, JS Ziegenfuss, et al. 2022. “Somatic Genomic Changes in Single Alzheimer’s Disease Neurons”. Nature 604 (7907): 714-22.
Search
Search results
65 results found
Somatic Mosaicism in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Reveals Widespread Degeneration from Focal Mutations
Zhou*, Zinan, Junho Kim*, August Yue Huang*, Matthew Nolan, Junseok Park, Ryan Doan, Taehwan Shin, et al. 2023. “Somatic Mosaicism in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Reveals Widespread Degeneration from Focal Mutations”. BioRxiv, Preprint.
Schizophrenia-associated somatic copy number variants from 12,834 cases reveal contribution to risk and recurrent, isoform-specific NRXN1 disruptions
Maury, Eduardo A., Maxwell A. Sherman, Giulio Genovese, Thomas G. Gilgenast, Prashanth Rajarajan, Erin Flaherty, Schahram Akbarian, et al. 2023. “Schizophrenia-Associated Somatic Copy Number Variants from 12,834 Cases Reveal Contribution to Risk and Recurrent, Isoform-Specific NRXN1 Disruptions”. Cell Genomics 3 (8).
Pan-cancer analysis reveals multifaceted roles of retrotransposon-fusion RNAs
Lee*, Boram, Junseok Park*, Adam Voshall, Eduardo A. Maury, Yeeok Kang, Yoen Jeong Kim, Jin-Young Lee, et al. 2023. “Pan-Cancer Analysis Reveals Multifaceted Roles of Retrotransposon-Fusion RNAs”. BioRxiv, Preprint.
A cell type-aware framework for nominating non-coding variants in Mendelian regulatory disorders
Lee**, Arthur S., Lauren J. Ayers, Michael Kosicki, Wai-Man Chan, Lydia N. Fozo, Brandon M. Pratt, Thomas E. Collins, et al. 2024. “A Cell Type-Aware Framework for Nominating Non-Coding Variants in Mendelian Regulatory Disorders”. Nature Communications, Accepted.
Large-scale clinical validation of biomarkers for pancreatic cancer using a mass spectrometry-based proteomics approach
Park, Jisook, Eunjung Lee, Kyoung-Jin Park, Hyung-Doo Park, Jong-Won Kim, Hye In Woo, Kwang Hyuck Lee, et al. 2017. “Large-Scale Clinical Validation of Biomarkers for Pancreatic Cancer Using a Mass Spectrometry-Based Proteomics Approach”. Oncotarget 8 (26): 42761-71.
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
Zhang, Yiqun, Patrick Kwok-Shing Ng, Melanie Kucherlapati, Fengju Chen, Yuexin Liu, Yiu Huen Tsang, Guillermo Velasco, et al. 2017. “A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/MTOR Pathway Alterations”. Cancer Cell 31 (6): 820-832.e3.
Next-generation sequencing-based detection of germline L1-mediated transductions
Tica*, Jelena, Eunjung Alice Lee*, Andreas Untergasser, Sascha Meiers, David Garfield, Omer Gokcumen, Eileen Furlong, Peter Park, Adrian Stütz, and Jan Korbel. 2016. “Next-Generation Sequencing-Based Detection of Germline L1-Mediated Transductions”. BMC Genomics 17 (1): 342.
Prediction of cancer prognosis with the genetic basis of transcriptional variations
Paik, Hyojung, Eunjung Lee, Inho Park, Junho Kim, and Doheon Lee. 2011. “Prediction of Cancer Prognosis With the Genetic Basis of Transcriptional Variations”. Genomics 97 (6): 350-7.
Relationships between genetic polymorphisms and transcriptional profiles for outcome prediction in anticancer agent treatment
Paik, Hyojung, Eunjung Lee, and Doheon Lee. 2010. “Relationships Between Genetic Polymorphisms and Transcriptional Profiles for Outcome Prediction in Anticancer Agent Treatment”. BMB Rep 43 (12): 836-41.